<DOC>
	<DOCNO>NCT02598466</DOCNO>
	<brief_summary>Research question : pattern patient-reported change physical function among adult patient use SC abatacept moderate severe RA since commencement compassionate use program ( CUP ) .</brief_summary>
	<brief_title>Patient-Reported Efficacy Subcutaneous ( SC ) Abatacept Rheumatoid Arthritis ( RA ) - South Africa</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>The global clinical trial associate longterm extension phase impose inclusion exclusion criterion . Only patient complete clinical trial longterm extension phase eligible inclusion CUP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>